BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10492400)

  • 1. Constitutive mdmx expression during cell growth, differentiation, and DNA damage.
    Jackson MW; Berberich SJ
    DNA Cell Biol; 1999 Sep; 18(9):693-700. PubMed ID: 10492400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mdm-2 phosphorylation by DNA-dependent protein kinase prevents interaction with p53.
    Mayo LD; Turchi JJ; Berberich SJ
    Cancer Res; 1997 Nov; 57(22):5013-6. PubMed ID: 9371494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
    Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
    EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiation.
    Mayo LD; Berberich SJ
    Oncogene; 1996 Dec; 13(11):2315-21. PubMed ID: 8957072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA binding activities of p53 protein following cisplatin damage of ovarian cells.
    Wetzel CC; Berberich SJ
    Oncol Res; 1998; 10(3):151-61. PubMed ID: 9700726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDMX inhibits the p300/CBP-mediated acetylation of p53.
    Sabbatini P; McCormick F
    DNA Cell Biol; 2002 Jul; 21(7):519-25. PubMed ID: 12162806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
    Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
    Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMX: a novel p53-binding protein with some functional properties of MDM2.
    Shvarts A; Steegenga WT; Riteco N; van Laar T; Dekker P; Bazuine M; van Ham RC; van der Houven van Oordt W; Hateboer G; van der Eb AJ; Jochemsen AG
    EMBO J; 1996 Oct; 15(19):5349-57. PubMed ID: 8895579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MdmX inhibits Smad transactivation.
    Kadakia M; Brown TL; McGorry MM; Berberich SJ
    Oncogene; 2002 Dec; 21(57):8776-85. PubMed ID: 12483531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MdmX protects p53 from Mdm2-mediated degradation.
    Jackson MW; Berberich SJ
    Mol Cell Biol; 2000 Feb; 20(3):1001-7. PubMed ID: 10629057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mdmx is a negative regulator of p53 activity in vivo.
    Finch RA; Donoviel DB; Potter D; Shi M; Fan A; Freed DD; Wang CY; Zambrowicz BP; Ramirez-Solis R; Sands AT; Zhang N
    Cancer Res; 2002 Jun; 62(11):3221-5. PubMed ID: 12036937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mdm2 association with p53 targets its ubiquitination.
    Fuchs SY; Adler V; Buschmann T; Wu X; Ronai Z
    Oncogene; 1998 Nov; 17(19):2543-7. PubMed ID: 9824166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mdmx promotes genomic instability independent of p53 and Mdm2.
    Carrillo AM; Bouska A; Arrate MP; Eischen CM
    Oncogene; 2015 Feb; 34(7):846-56. PubMed ID: 24608433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a domain within MDMX-S that is responsible for its high affinity interaction with p53 and high-level expression in mammalian cells.
    Rallapalli R; Strachan G; Tuan RS; Hall DJ
    J Cell Biochem; 2003 Jun; 89(3):563-75. PubMed ID: 12761890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of p53-MDMX interaction by casein kinase 1 alpha.
    Chen L; Li C; Pan Y; Chen J
    Mol Cell Biol; 2005 Aug; 25(15):6509-20. PubMed ID: 16024788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the proportion of p53 bound to mdm-2 in cells with defined growth characteristics.
    Momand J; Zambetti GP
    Oncogene; 1996 Jun; 12(11):2279-89. PubMed ID: 8649767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mdm-2 gene amplification in 3T3-L1 preadipocytes.
    Berberich SJ; Litteral V; Mayo LD; Tabesh D; Morris D
    Differentiation; 1999 May; 64(4):205-12. PubMed ID: 10365438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts.
    Gentiletti F; Mancini F; D'Angelo M; Sacchi A; Pontecorvi A; Jochemsen AG; Moretti F
    Oncogene; 2002 Jan; 21(6):867-77. PubMed ID: 11840332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2.
    Shieh SY; Ikeda M; Taya Y; Prives C
    Cell; 1997 Oct; 91(3):325-34. PubMed ID: 9363941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation.
    Jin Y; Dai MS; Lu SZ; Xu Y; Luo Z; Zhao Y; Lu H
    EMBO J; 2006 Mar; 25(6):1207-18. PubMed ID: 16511572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.